Abstract
Starting from an HTS derived hit 1, application of biostructural data facilitated rapid optimization to lead 22, a novel AMPA receptor modulator. This is the first demonstration of how structure based drug design can be exploited in an optimization program for a glutamate receptor.
Original language | English |
---|---|
Pages (from-to) | 5753-5756 |
Number of pages | 4 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 20 |
Issue number | 19 |
Early online date | 13 Aug 2010 |
DOIs | |
Publication status | Published - 1 Oct 2010 |
Keywords
- AMPA receptor
- hit-to-lead
- SBDD
- allosteric modulator